An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocol

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Blackberry, Irene D ^a   Furler, John S ^a   Ginnivan, Louise E ^a   Derraz, Hanan ^b   Jenkins, Alicia ^a   Cohen, Neale ^b   Best, James D ^c   Young, Doris ^a   Liew, Danny ^a   Ward, Glenn ^d   Manski Nankervis, Jo Anne ^a   O'Neal, David N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Family medicine; Insulin; Nurse; Primary care; Retrospective continuous glucose monitoring; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ADULT; AGED; AUSTRALIA; BLOOD; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; INTERVENTION STUDY; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PRIMARY HEALTH CARE; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE SELF-MONITORING; CLINICAL PROTOCOLS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERVENTION STUDIES; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; TREATMENT OUTCOME; VICTORIA;

EID: 84901797372     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-15-82     Document Type: Article

References (40)

1. WHO Prevalence of diabetes. World Health Organisation, [updated Accessed March 2010; cited http://www.who.int/diabetes/actionnow/en/mapdiabprev.pdf ]
2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR, BMJ 2000 321 7258 405 412 10.1136/bmj.321.7258.405 10938048
3. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P, Diabet Med 2007 24 12 1412 1418 10.1111/j.1464-5491.2007.02279.x 18042083
4. Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain. Costi M, Dilla T, Reviriego J, Castell C, Goday A, Acta Diabetol 2010 47 Suppl 1 169 175 19855919
5. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, Diabetes Care 2012 35 6 1364 1379 10.2337/dc12-0413 22517736
6. Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study. Davis TME, Davis WA, Bruce DG, Med J Aus 2006 184 7 325 328
7. Australian National Diabetes Information Audit and Benchmarking, ANDIAB 2009 Canberra: National Association of Diabetes Centres 2009
8. A retrospective database study of insulin initiation in patients with Type 2 diabetes in UK primary care. Blak BT, Smith HT, Hards M, Maguire A, Gimeno V, Diabet Med 2012 29 8 191 198 10.1111/j.1464-5491.2012.03694.x 22507537
9. Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study. Dale J, Martin S, Gadsby R, Primary Care Diabetes 2010 4 2 85 89 10.1016/j.pcd.2010.03.001 20392683
10. Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial. Harris S, Yale J-F, Dempsey E, Gerstein H, Can Fam Physician 2008 54 4 550 558 18411384
11. Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin. Blak BT, Smith HT, Hards M, Curtis BH, Ivanyi T, Diabet Med 2012 29 7 13 20 10.1111/j.1464-5491.2012.03586.x
12. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Monnier L, Colette C, Dunseath GJ, Owens DR, Diabetes Care 2007 30 2 263 269 10.2337/dc06-1612 17259492
13. Three-year efficacy of complex insulin regimens in type 2 diabetes. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK, N Engl J Med 2009 361 18 1736 1747 10.1056/NEJMoa0905479 19850703
14. Basal plus basal-bolus approach in type 2 diabetes. Ampudia-Blasco FJ, Rossetti P, Ascaso JF, Diabetes Technol Ther 2011 13 Suppl 1(1) 75 83 21668340
15. Accuracy of self-monitored blood glucose in type 2 diabetes. Kazlauskaite R, Soni S, Evans AT, Graham K, Fisher B, Diabetes Technol Ther 2009 11 6 385 392 10.1089/dia.2008.0111 19459768
16. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV, Diabetes Care 2001 24 11 1858 1862 10.2337/diacare.24.11.1858 11679447
17. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Hay LC, Wilmshurst EG, Fulcher G, Diabetes Technol Ther 2003 5 1 19 26 10.1089/152091503763816427 12725703
18. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. Golden SH, Sapir T, J Manag Care Pharm 2012 18 6 Suppl B 1 17
19. Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? Monnier L, Colette C, Boegner C, Pham TC, Lapinski H, Boniface H, Diabetes Metab 2007 33 4 247 252 10.1016/j.diabet.2006.11.007 17320449
20. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH, Ann Intern Med 2012 157 5 336 347 10.7326/0003-4819-157-5-201209040-00508 22777524
21. Insulin in general practice-barriers and enablers for timely initiation. Furler J, Spitzer O, Young D, Best J, Aust Fam Physician 2011 40 8 617 621 21814661
22. Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial. Harris SB, Gerstein HC, Yale JF, Berard L, Stewart J, Webster-Bogaert S, Tompkins JW, BMC Health Serv Res 2013 13 71 71 23433347
23. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, Moffet HH, Marrero DG, Diabetes Care 2010 33 4 733 735 10.2337/dc09-1184 20086256
24. Furler J, Blackberry I, Young D, Best J, Stepping Up: Perceptions Of Insulin Initiation In General Practice: Pilot Of An Innovative Model Of Care. General Practice And Primary Health Care Research Conference Darwin, Australia: Primary Health Care Research Information Service 2010
25. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes. Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R, Diabetes Care 2005 28 6 1282 1288 10.2337/diacare.28.6.1282 15920040
26. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Jarvinen H, Diabetes Care 2005 28 2 254 259 10.2337/diacare.28.2.254 15677775
27. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A, Diabetes Care 2005 28 2 260 265 10.2337/diacare.28.2.260 15677776
28. Ware JEJ, Kosinski M, Dewey JE, Version 2 of the SF-36® Health Survey Lincoln, RI: QualityMetric Incorporated 2003
29. Usefulness of the audit of diabetes-dependent quality-of-Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian country. Wee HL, Tan CE, Goh SY, Li SC, Pharmacoeconomics 2006 24 7 673 682 10.2165/00019053- 200624070-00006 16802843
30. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]. Scott R, Best J, Forder P, Taskinen MR, Simes J, Barter P, Keech A, Cardiovasc Diabetol 2005 4 13 13 16111499
31. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV, Diabetes Care 2005 28 10 2543 2545 10.2337/diacare.28.10.2543 16186296
32. Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study. Owens DR, Luzio SD, Sert-Langeron C, Riddle MC, Diabetes Obes Metab 2011 13 11 1020 1027 10.1111/j.1463-1326.2011.01459.x 21679291
33. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs. Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA, Diabetes Obes Metab 2008 10 12 1178 1185 19040645
34. Continuous glucose monitoring: comparing real-time and retrospective devices. O'Neal D, Jenkins AJ, Infusystems USA 2010 7 4 26 30
35. Frequent hypoglycemia among elderly patients with poor glycemic control. Munshi MN, Segal AR, Suhl E, Staum E, Desrochers L, Sternthal A, Giusti J, McCartney R, Lee Y, Bonsignore P, Weinger K, Arch Intern Med 2011 171 4 362 364 10.1001/archinternmed.2010.539 21357814
36. The use of continuous glucose monitoring in patients with type 2 diabetes. Meade LT, Diabetes Technol Ther 2012 14 2 190 195 10.1089/dia.2011. 0086 21933000
37. Developing and evaluating complex interventions: the new Medical Research Council guidance. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, BMJ 2008 337 337 1655 18824488
38. A rational model for assessing and evaluating complex interventions in health care. May C, BMC Health Services Research 2006 6 1 86 10.1186/1472-6963-6-86 16827928
39. Stepping up: a nurse-led model of care for insulin initiation for people with type 2 diabetes. Furler JS, Blackberry ID, Walker C, Manski-Nankervis JA, Anderson J, O'Neal D, Young D, Best J, Fam Pract. 2014 28 28
40. Framework for design and evaluation of complex interventions to improve health. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P, BMJ 2000 321 7262 694 696 10.1136/bmj.321.7262.694 10987780